123 filings
8-K
SLRX
Salarius Pharmaceuticals Inc
6 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
SLRX
Salarius Pharmaceuticals Inc
22 Feb 24
Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
5:55pm
8-K
SLRX
Salarius Pharmaceuticals Inc
6 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:09pm
8-K
SLRX
Salarius Pharmaceuticals Inc
10 Aug 23
Salarius Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:14pm
8-K
SLRX
Salarius Pharmaceuticals Inc
12 Jul 23
Other Events
9:22am
8-K
2wem594l8ft7pco08dl
14 Jun 23
Departure of Directors or Certain Officers
6:47pm
8-K
jct qklls
16 May 23
Salarius Pharmaceuticals Announces $6 Million Private Placement
4:33pm
8-K
1wr2pdwh9irclj 9fpt
13 Mar 23
Other Events
8:55am
8-K
96a90
10 Jan 23
Salarius Pharmaceuticals Announces Issuance of New U.S. Patent for Next-Generation Targeted Protein Degraders
11:11am
8-K
yx1xtfp4ts0c3
1 Dec 22
Salarius Pharmaceuticals Announces Interim Results from Phase 1/2 Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas
8:14am
8-K
2c5td7qf3fs9
10 Nov 22
Salarius Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
8:38am
8-K
pnz8c1ug3ry2lg
3 Nov 22
Other Events
9:28am
8-K
3kouni
27 Oct 22
Salarius Pharmaceuticals Presents Favorable Preclinical Data on SP-3164 at the 5th Annual Targeted Protein Degradation Conference
8:34am
8-K
xhc0ew6gb5o
18 Oct 22
Other Events
8:41am
8-K
qm3qm2 bco
14 Oct 22
Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split
8:55am
8-K
kzl6v9bfnzorh3 bq
12 Aug 22
Salarius Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
6:16pm
8-K
yj6ciz
3 Aug 22
Salarius Pharmaceuticals and VolitionRx Enter into R&D Collaboration Agreement
4:27pm
8-K
j56uq29xusm79vt
17 Jun 22
Submission of Matters to a Vote of Security Holders
5:03pm
8-K
6a66s1wik3hk
12 May 22
Salarius Pharmaceuticals Reports Business Highlights with First Quarter 2022 Financial Results
4:14pm
8-K
cctxoge dey
26 Apr 22
Other Events
5:14pm